has developed a new biomaterial with high potential in the treatment of bone lesions or minimal residual disease in multiple myeloma patients. The findings showcase a promising approach to bone ...

Early treatment with intravenous bisphosphonates at first radiographic evidence of bone lesions in patients with ... Treatments such as radiation therapy to palliate bone pain or surgery to ...

The team tackled a critical challenge in treating multiple myeloma -- a blood cancer where malignant plasma cells accumulate in bone marrow, leading to debilitating bone lesions in 80% of patients.

including those resistant to systemic bortezomib treatment. The results show promising potential for stabilization and healing of fracture-prone bone lesions. The research team envisions sicXer ...

Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumours, such as thyroid, lymphomas or bone metastases, delivering radiation to tumorous lesions as part of a therapeutic strategy ...